Suppr超能文献

经肛门括约肌间瘘管结扎术治疗肛瘘的早期结果。

Early result of ligation of the intersphincteric fistula tract for fistula-in-ano.

机构信息

Division of Colon and Rectal Surgery, Harbor-UCLA Medical Center, Torrance, CA, USA.

出版信息

Dis Colon Rectum. 2011 Mar;54(3):289-92. doi: 10.1007/DCR.0b013e318203495d.

Abstract

PURPOSE

The ligation of the intersphincteric fistula tract is a new surgical procedure without any use of biologic material. The purpose of this study is to present our early results with this novel technique.

METHODS

A retrospective review of patients who underwent the procedure for high transsphincteric fistulas was analyzed. The procedure was performed by a single surgeon. Patient and fistula characteristics, complications, and recurrences were reviewed.

RESULTS

Twenty-five patients underwent the ligation of intersphincteric fistula tract procedure. All the patients had transsphincteric fistulas that were not suitable for fistulotomy. All patients underwent the procedure on an outpatient basis with a median follow-up of 24 weeks (range, 8-52 wk). Of the 25 patients, 17 (68%) healed completely and did not require any further surgical treatment. Eight of the 25 patients had persistent symptoms: 5 patients had a clear tract with an internal opening, 2 patients had a draining sinus without an identifiable internal opening, and 1 patient presented with an intersphincteric fistula, which was at the site of the intersphincteric groove incision. There were no statistically significant differences in recurrence rates with regard to the presence of a seton at the time of surgery, history of previous operations such as mucosal advancement flap, or seton placement.

CONCLUSION

The ligation of intersphincteric fistula is a promising sphincter-preserving procedure that is simple and safe, and it does not require expensive biologic material. Our early data confirm a low recurrence rate with a primary healing rate of 68%.

摘要

目的

括约肌间瘘管结扎术是一种新的手术方法,不使用任何生物材料。本研究旨在介绍该新技术的早期结果。

方法

回顾性分析了 25 例行该手术的高位经括约肌型肛瘘患者。该手术由一名外科医生完成。回顾了患者和瘘管特征、并发症和复发情况。

结果

25 例患者接受了括约肌间瘘管结扎术。所有患者的经括约肌型肛瘘均不适合行瘘管切开术。所有患者均在门诊接受该手术,中位随访时间为 24 周(8-52 周)。25 例患者中,17 例(68%)完全愈合,无需进一步手术治疗。25 例患者中有 8 例仍有持续性症状:5 例有明确的瘘管伴内口,2 例有引流窦但无可识别的内口,1 例表现为位于括约肌间沟切口处的经括约肌型肛瘘。手术时是否存在皮筋、是否有先前的黏膜推进皮瓣或皮筋放置等手术史,与复发率无统计学差异。

结论

括约肌间瘘管结扎术是一种有前景的保肛手术方法,简单安全,不需要昂贵的生物材料。我们的早期数据证实,该手术的原发愈合率为 68%,复发率低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验